EGFR and Hepatic fibrosis: In the current study, Src inhibition attenuated TGF-β-induced phospho-EGFR expression in AML12 cells and primary hepatocytes (Supplementary Figure S6); however, the effect of this inhibition on TAA-induced liver fibrosis is unclear.